NASDAQ: INTC
INTEL CORPCIK 0000050863 · SIC 3674 · Semiconductors
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (WKC 10-Q) is open in full — no account needed.
Intel's Q3 revenue rose 20.9% to $16.51B, but net income attributable to Intel fell 18.3% to $3.32B, which includes the prior-year $5.5 billion pre-tax gain in interest and other, net related to the sale of 51% of Altera.
5 material changes detected. Sign up free to read the summary.
Summary not yet generated.
Partner
Trade INTC commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Intel raises $19.7B net in common stock offering, upsized to $20B gross at $95/share
4 material changes detected. Sign up free to read the summary.
Intel prices $19.7B follow-on offering at $97.52/share for capex and working capital
4 material changes detected. Sign up free to read the summary.
Intel offering common stock at market; size and price not disclosed in preliminary 424B5
4 material changes detected. Sign up free to read the summary.
Q2 2026: revenue $16.1B, net income -$11.0B. Revenue +25% on premium mix, but net loss widens 278% on escrow charge
5 material changes detected. Sign up free to read the summary.
Intel reports Q2 revenue up 25% YoY to $16.1B, GAAP loss of $(2.16)/share on CHIPS Act charge
5 material changes detected. Sign up free to read the summary.
Intel stockholders approve executive pay, equity plans at annual meeting
4 material changes detected. Sign up free to read the summary.
Intel raises $6.5B in debt across five tranches with rates up to 6.2% for 40-year bonds
5 material changes detected. Sign up free to read the summary.
revenue $13.6B, net income -$3.73B. Intel posts Mobileye impairment as Iran conflict threatens Israel fab, 14A node at risk
5 material changes detected. Sign up free to read the summary.
Intel's Chief Accounting Officer Scott Gawel resigns immediately; CFO takes dual role
2 material changes detected. Sign up free to read the summary.
Intel reports Q1 2026 earnings and Q2 guidance in routine quarterly disclosure
2 material changes detected. Sign up free to read the summary.
Intel repurchases Apollo's 49% Fab 34 stake for $14.2B, adds $6.5B bridge debt
4 material changes detected. Sign up free to read the summary.
revenue $52.9B, net income -$267.0M. Intel, equity sales; divests Altera; warns supply constraints persist
5 material changes detected. Sign up free to read the summary.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed Oct 30, 2026 (period ending Sep 26, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Consolidated Condensed Statements of Operations
(In Millions, Except Per Share Amounts; Unaudited)
| Description | Three months ended Sep 26, 2026 | Three months ended Sep 27, 2025 | Nine months ended Sep 26, 2026 | Nine months ended Sep 27, 2025 |
|---|---|---|---|---|
| Net revenue | 16,513 | 13,653 | 46,218 | 39,179 |
| Cost of sales | 9,417 | 8,435 | 27,266 | 25,747 |
| Gross profit | 7,096 | 5,218 | 18,952 | 13,432 |
| Research and development | 3,490 | 3,231 | 10,233 | 10,555 |
| Marketing, general, and administrative | 1,030 | 1,129 | 3,243 | 3,450 |
| Restructuring and other charges | 54 | 175 | 4,294 | 2,221 |
| Operating expenses | 4,574 | 4,535 | 17,770 | 16,226 |
| Operating income (loss) | 2,522 | 683 | 1,182 | (2,794) |
| Gains (losses) on equity investments, net | 330 | 221 | 219 | 611 |
| Interest and other, net | 1,130 | 3,670 | (12,184) | 3,402 |
| Income (loss) before taxes | 3,982 | 4,574 | (10,783) | 1,219 |
| Provision for (benefit from) taxes | 462 | 304 | 826 | 860 |
| Net income (loss) | 3,520 | 4,270 | (11,609) | 359 |
| Less: net income (loss) attributable to non-controlling interests | 200 | 207 | (168) | 35 |
| Net income (loss) attributable to Intel | 3,320 | 4,063 | (11,441) | 324 |
| Earnings (loss) per share attributable to Intel—basic | 0.63 | 0.90 | (2.22) | 0.07 |
| Earnings (loss) per share attributable to Intel—diluted¹ | 0.60 | 0.90 | (2.22) | 0.07 |
| Weighted average shares of common stock outstanding: | ||||
| Basic | 5,244 | 4,514 | 5,144 | 4,424 |
| Diluted | 5,307 | 4,531 | 5,144 | 4,434 |
Consolidated Condensed Balance Sheets
(In Millions; Unaudited)
| Description | Sep 26, 2026 | Dec 27, 2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | 21,846 | 14,265 |
| Short-term investments | 32,159 | 23,151 |
| Accounts receivable, net | 4,093 | 3,839 |
| Inventories | 13,068 | 11,618 |
| Other current assets | 11,408 | 10,815 |
| Total current assets | 82,574 | 63,688 |
| Property, plant, and equipment, net of accumulated depreciation of $111,913 ($106,464 as of December 27, 2025) | 105,314 | 105,414 |
| Equity investments | 8,798 | 8,512 |
| Goodwill | 20,465 | 23,912 |
| Identified intangible assets, net | 2,444 | 2,772 |
| Other long-term assets | 8,979 | 7,131 |
| Total assets | 228,574 | 211,429 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | 8,831 | 9,882 |
| Accrued compensation and benefits | 3,905 | 3,990 |
| Short-term debt | 3,817 | 2,499 |
| Other accrued liabilities | 20,843 | 15,204 |
| Total current liabilities | 37,396 | 31,575 |
| Debt | 46,317 | 44,086 |
| Other long-term liabilities | 13,305 | 9,408 |
| Commitments and Contingencies (Note 14) | ||
| Stockholders’ equity: | ||
| Common stock and capital in excess of par value, 5,310 issued and outstanding (4,994 issued and outstanding as of December 27, 2025) | 78,177 | 65,185 |
| Accumulated other comprehensive income (loss) | (232) | 113 |
| Retained earnings | 36,969 | 48,983 |
| Total Intel stockholders' equity | 114,914 | 114,281 |
| Non-controlling interests | 16,642 | 12,079 |
| Total stockholders' equity | 131,556 | 126,360 |
| Total liabilities and stockholders’ equity | 228,574 | 211,429 |
Consolidated Condensed Statements of Cash Flows
(In Millions; Unaudited)
| Description | Nine months ended Sep 26, 2026 | Nine months ended Sep 27, 2025 |
|---|---|---|
| Cash, cash equivalents, and restricted cash, beginning of period | 14,712 | 8,249 |
| Cash flows provided by (used for) operating activities: | ||
| Net income (loss) | (11,609) | 359 |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||
| Depreciation | 8,933 | 7,971 |
| Share-based compensation | 1,894 | 1,896 |
| Restructuring and other charges | 3,969 | 372 |
| Amortization of intangibles | 659 | 708 |
| (Gains) losses on equity investments, net | (219) | (611) |
| Mark-to-market (gains) losses on Escrowed Shares | 12,614 | 1,687 |
| (Gains) losses on divestitures | 18 | (5,355) |
| Deferred taxes | 56 | 123 |
| Impairments and net (gain) loss on retirement of property, plant, and equipment | 140 | 465 |
| Changes in assets and liabilities: | ||
| Accounts receivable | (281) | 162 |
| Inventories | (1,450) | (9) |
| Accounts payable | 821 | (281) |
| Accrued compensation and benefits | (207) | 541 |
| Income taxes | (405) | (1,196) |
| Other assets and liabilities | (1,749) | (1,423) |
| Total adjustments | 24,793 | 5,050 |
| Net cash provided by (used for) operating activities | 13,184 | 5,409 |
| Cash flows provided by (used for) investing activities: | ||
| Additions to property, plant, and equipment | (10,216) | (11,158) |
| Proceeds from capital-related government incentives | 215 | 1,018 |
| Acquisitions, net of cash acquired | (596) | — |
| Purchases of short-term investments | (32,151) | (16,401) |
| Maturities of short-term investments | 10,767 | 8,236 |
| Sales of short-term investments | 11,911 | 2,728 |
| Sales of equity investments | 401 | 642 |
| Proceeds from divestitures, net | — | 6,186 |
| Other investing | (590) | 494 |
| Net cash provided by (used for) investing activities | (20,259) | (8,255) |
| Cash flows provided by (used for) financing activities: | ||
| Issuance of commercial paper, net of issuance costs | — | 3,493 |
| Repayment of commercial paper | — | (3,493) |
| Payments on finance leases | (951) | (103) |
| Partner contributions | 5,032 | 3,652 |
| Partner distributions | (14,442) | (159) |
| Net proceeds from sales of subsidiary shares | — | 922 |
| Additions to property, plant, and equipment | (1,618) | (2,493) |
| Issuance of term debt, net of issuance costs | 13,000 | — |
| Repayments of term debt | (9,000) | (3,750) |
| Proceeds from sales of common stock through employee equity incentive plans | 736 | 777 |
| Net proceeds attributed to common stock and warrants issued, and Escrowed Shares | 440 | 7,682 |
| Net proceeds from public offering of common stock | 22,617 | — |
| Restricted stock unit withholdings | (907) | (286) |
| Other financing | (146) | (504) |
| Net cash provided by (used for) financing activities | 14,761 | 5,738 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 7,686 | 2,892 |
| Cash, cash equivalents, and restricted cash, end of period | 22,398 | 11,141 |
Amounts as printed on the EDGAR/iXBRL face — (In Millions, Except Per Share Amounts; Unaudited); (In Millions; Unaudited). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗